content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation
and recommendation
Osiris Therapeutics, Inc. (OSIR)
0.00
(0.00%)
content_middle
Osiris Therapeutics (OSIR) researches, develops, manufactures, markets, and distributes regenerative medicine products.
OSIR products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns; BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery; and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects.
Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.
Previous Close:
5.80
Open:
5.76
Bid:
N/A
Ask:
N/A
1yr Target Price:
4.00
Day's Range:
5.76 - 5.89
52wk Range:
7.01 - 19.30
Volume:
7613
Average Daily Volume:
24675
Market Capitalization:
655.69M
Trailing Annual Dividend Yield:
0.00
Shares Outstanding:
34.53M
content_right
- May 17, 2012 - 6:57pm | Regulatory
- May 16, 2012 - 9:07am | Scoreboard at a Glance
- May 11, 2012 - 8:52am | Earnings
- March 9, 2012 - 1:00pm
- February 13, 2012 - 11:58am
- February 9, 2012 - 11:24am
- January 24, 2012 - 9:28am
- November 7, 2011 - 9:38am
- August 8, 2011 - 7:57am
- August 5, 2011 - 8:17am
- May 9, 2011 - 10:27am
- March 16, 2011 - 9:24am
- March 7, 2011 - 9:07pm
- March 2, 2011 - 9:24am
- February 18, 2011 - 4:42pm
- February 17, 2011 - 12:38pm
- February 11, 2011 - 7:56am
- February 7, 2011 - 1:19pm
- February 2, 2011 - 8:13am
- November 5, 2010 - 1:02pm